메뉴 건너뛰기




Volumn 176, Issue 7, 2002, Pages 332-334

The road to consensus: Considerations for the safe use and prescribing of COX-2-specific inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 0036531077     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (14)
  • 1
    • 0036531728 scopus 로고    scopus 로고
    • Considerations for the safe prescribing and use of COX-2-specific inhibitors
    • (2002) Med J Aust , vol.176 , pp. 328-328
  • 2
    • 0034644396 scopus 로고    scopus 로고
    • Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: A randomised controlled trial
    • (2000) JAMA , vol.284 , pp. 1247-1255
    • Silverstein, F.E.1    Faich, G.2    Goldstein, J.L.3
  • 4
    • 0006188131 scopus 로고    scopus 로고
  • 11
    • 0035286901 scopus 로고    scopus 로고
    • Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomised, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
    • (2001) Am J Therapeutics , vol.8 , pp. 85-95
    • Whelton, A.1    Fort, J.G.2    Puma, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.